581 related articles for article (PubMed ID: 33089317)
1. Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
Baang JH; Smith C; Mirabelli C; Valesano AL; Manthei DM; Bachman MA; Wobus CE; Adams M; Washer L; Martin ET; Lauring AS
J Infect Dis; 2021 Jan; 223(1):23-27. PubMed ID: 33089317
[TBL] [Abstract][Full Text] [Related]
2. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
Camprubí D; Gaya A; Marcos MA; Martí-Soler H; Soriano A; Mosquera MDM; Oliver A; Santos M; Muñoz J; García-Vidal C
Int J Infect Dis; 2021 Mar; 104():379-381. PubMed ID: 33359065
[TBL] [Abstract][Full Text] [Related]
3. Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation.
Glueck OM; Liang X; Badell I; Wratil PR; Graf A; Krebs S; Blum H; Hellmuth JC; Scherer C; Hollaus A; Spaeth PM; Karakoc B; Fuchs T; Zimmermann J; Kauke T; Moosmann A; Keppler OT; Schneider C; Muenchhoff M
Infection; 2024 Jun; 52(3):847-855. PubMed ID: 37922037
[TBL] [Abstract][Full Text] [Related]
4. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
Buckland MS; Galloway JB; Fhogartaigh CN; Meredith L; Provine NM; Bloor S; Ogbe A; Zelek WM; Smielewska A; Yakovleva A; Mann T; Bergamaschi L; Turner L; Mescia F; Toonen EJM; Hackstein CP; Akther HD; Vieira VA; Ceron-Gutierrez L; Periselneris J; Kiani-Alikhan S; Grigoriadou S; Vaghela D; Lear SE; Török ME; Hamilton WL; Stockton J; Quick J; Nelson P; Hunter M; Coulter TI; Devlin L; ; ; Bradley JR; Smith KGC; Ouwehand WH; Estcourt L; Harvala H; Roberts DJ; Wilkinson IB; Screaton N; Loman N; Doffinger R; Lyons PA; Morgan BP; Goodfellow IG; Klenerman P; Lehner PJ; Matheson NJ; Thaventhiran JED
Nat Commun; 2020 Dec; 11(1):6385. PubMed ID: 33318491
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic or relapsing COVID-19 in immunodeficiency.
Brown LK; Moran E; Goodman A; Baxendale H; Bermingham W; Buckland M; AbdulKhaliq I; Jarvis H; Hunter M; Karanam S; Patel A; Jenkins M; Robbins A; Khan S; Simpson T; Jolles S; Underwood J; Savic S; Richter A; Shields A; Brown M; Lowe DM
J Allergy Clin Immunol; 2022 Feb; 149(2):557-561.e1. PubMed ID: 34780850
[TBL] [Abstract][Full Text] [Related]
6. Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19.
DeVine MN; Maxwell S; Haynes AS; MacBrayne CE; Boguniewicz J
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e293-e295. PubMed ID: 33235142
[TBL] [Abstract][Full Text] [Related]
7. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Abraham RS; Marshall JM; Kuehn HS; Rueda CM; Gibbs A; Guider W; Stewart C; Rosenzweig SD; Wang H; Jean S; Peeples M; King T; Hunt WG; Honegger JR; Ramilo O; Mustillo PJ; Mejias A; Ardura MI; Shimamura M
J Allergy Clin Immunol; 2021 Feb; 147(2):532-544.e1. PubMed ID: 33007327
[TBL] [Abstract][Full Text] [Related]
8. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
10. Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19.
Igari H; Sakao S; Ishige T; Saito K; Murata S; Yahaba M; Taniguchi T; Suganami A; Matsushita K; Tamura Y; Suzuki T; Ido E
Nat Commun; 2024 Apr; 15(1):3604. PubMed ID: 38684722
[TBL] [Abstract][Full Text] [Related]
11. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study.
Belogiannis K; Florou VA; Fragkou PC; Ferous S; Chatzis L; Polyzou A; Lagopati N; Vassilakos D; Kittas C; Tzioufas AG; Tsiodras S; Sourvinos G; Gorgoulis VG
Viruses; 2021 Jun; 13(6):. PubMed ID: 34198719
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
[TBL] [Abstract][Full Text] [Related]
14. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
15. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure.
Keitel V; Bode JG; Feldt T; Walker A; Müller L; Kunstein A; Klindt C; Killer A; Senff T; Timm J; Ostermann P; Damagnez M; Lübke N; Adams O; Schaal H; Antoch G; Neubert J; Albrecht P; Meuth S; Elben S; Mohring A; Fischer JC; Bölke E; Hoenig M; Schulz AS; Luedde T; Jensen B
Front Immunol; 2021; 12():645989. PubMed ID: 34012436
[TBL] [Abstract][Full Text] [Related]
18. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
[TBL] [Abstract][Full Text] [Related]
19. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
[TBL] [Abstract][Full Text] [Related]
20. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
Front Immunol; 2021; 12():664619. PubMed ID: 34305895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
